Biodegradable Microspheres Deliver Time Release Vaccines, Stimulate Different Immune Response

A new vaccine delivery system using microspheres of a biodegradable polymer may not only reduce the need for booster shots in some cases, but also appears to stimulate an immune response that traditional vaccines do not. Researchers from Iowa State University reported their findings at the ASM Biodefense and Emerging Disease Research Meeting. "Current vaccines are good at producing antibodies that block entry into the cell. In the case of some diseases, such as malaria or tuberculosis, antibody vaccines just aren't effective," says Jenny Wilson-Welder, a lead researcher on the study. Wilson-Welder and her colleagues initially began their research looking for a way to eliminate the need for booster vaccinations, by developing a vaccine delivery system that released the vaccine into the system slowly over time. They chose a biodegradable polymer, called polyandydride, in a microsphere formulation. This polymer was already being used as a delivery system for a brain cancer drug designed to inhibit tumor growth. "It's like an Everlasting Gobstopper or a bar of soap. It wears away slowly over time, delivering its payload," says Wilson-Welder. The researchers vaccinated mice with microspheres loaded with ovalbumin, a protein from chicken eggs, and measured immune reponse. While mice exhibited the expected antibody response, the researchers also noticed something unexpected. The vaccine enhanced another type of immune response known as cellular-mediated immunity (CMI). CMI allows the immune system to identify, target and kill... Whole article: "www.medicalnewstoday.com":[ http://www.medicalnewstoday.com/medicalnews.php?newsid=64228]

---

Related articles

Nanoparticle Boost for Antitumor Vaccines - Researchers have known for some time that certain sequences of synthetic DNA induce potent immune responses when injected into animals and humans (21.2.2007)

Scientists Unveil Piece Of HIV Protein That May Be Key To AIDS Vaccine Development - In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an infection-fighting antibody (20.2.2007)

Peptide Vaccine Fights Off Breast Tumors with Aid of Bacteria-mimicking Agents - With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice (6.2.2007)

Vaccine hope for developing world - The new "Trojan horse" vaccines use genetically-engineered viruses which get inside cells and stimulate a strong immune response by the body to the killer diseases (30.1.2007)

Study Models Impact Of Anthrax Vaccine - Rapidly distributing antibiotics to people exposed to anthrax spores during a bioterrorist attack, could by itself, prevent about 70 percent of anthrax infections from occurring, according to researchers from the Johns Hopkins Bloomberg School of Public Health (19.10.2006)